Aberdeen Group’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-141,186
| Closed | -$8.53M | – | 959 |
|
|
2025
Q1 | $8.53M | Buy |
141,186
+5,249
| +4% | +$317K | 0.02% | 602 |
|
|
2024
Q4 | $9.4M | Sell |
135,937
-29,841
| -18% | -$2.06M | 0.02% | 522 |
|
|
2024
Q3 | $11.9M | Sell |
165,778
-14,859
| -8% | -$1.07M | 0.02% | 487 |
|
|
2024
Q2 | $12.5M | Sell |
180,637
-8,232
| -4% | -$571K | 0.02% | 473 |
|
|
2024
Q1 | $15.1M | Sell |
188,869
-23,985
| -11% | -$1.92M | 0.03% | 471 |
|
|
2023
Q4 | $23.3M | Sell |
212,854
-22,338
| -9% | -$2.45M | 0.05% | 354 |
|
|
2023
Q3 | $23.7M | Sell |
235,192
-48,704
| -17% | -$4.91M | 0.06% | 293 |
|
|
2023
Q2 | $38.6M | Sell |
283,896
-127,957
| -31% | -$17.4M | 0.09% | 211 |
|
|
2023
Q1 | $42.8M | Sell |
411,853
-40,485
| -9% | -$4.2M | 0.11% | 192 |
|
|
2022
Q4 | $40.1M | Buy |
452,338
+99,564
| +28% | +$8.83M | 0.11% | 204 |
|
|
2022
Q3 | $28.3M | Buy |
352,774
+22,644
| +7% | +$1.82M | 0.08% | 253 |
|
|
2022
Q2 | $33M | Buy |
330,130
+60,810
| +23% | +$6.08M | 0.1% | 212 |
|
|
2022
Q1 | $40.3M | Sell |
269,320
-75,191
| -22% | -$11.2M | 0.1% | 208 |
|
|
2021
Q4 | $48.8M | Buy |
344,511
+30,798
| +10% | +$4.37M | 0.11% | 193 |
|
|
2021
Q3 | $41.3M | Buy |
313,713
+42,134
| +16% | +$5.55M | 0.09% | 223 |
|
|
2021
Q2 | $37.3M | Buy |
+271,579
| New | +$37.3M | 0.08% | 233 |
|